Combination antiviral therapy (DrugBank: -)
1 disease| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 93 | 原発性胆汁性胆管炎［原発性胆汁性肝硬変 (~2017.3)］ | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00490620 (ClinicalTrials.gov) | January 2004 | 21/6/2007 | Study of Combivir for Patients With Primary Biliary Cirrhosis | Randomized Controlled Pilot Study of Combivir for Patients With Primary Biliary Cirrhosis | Primary Biliary Cirrhosis | Drug: Combination antiviral therapy;Drug: Placebo | University of Alberta | GlaxoSmithKline;Axcan Pharma | Completed | 18 Years | 75 Years | Both | 59 | Phase 2;Phase 3 | United States;Canada;United Kingdom |